A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations

PHASE3WithdrawnINTERVENTIONAL

Timeline

Start Date

August 31, 2016

Primary Completion Date

October 15, 2018

Study Completion Date

October 15, 2018

Conditions

Parkinson's Disease

Interventions

DRUG

ND0612

DRUG

Placebo

Trial Locations (1)

Haddasah Ein Kerem Medical center, Jerusalem